Multimodal AI Model Predicts Breast Cancer Recurrence.

An artificial intelligence model that incorporates a range of tumor and patient data proved significantly more accurate in retrospectively predicting breast cancer recurrence than a commonly used genomic test, suggesting that multimodal models could be leveraged to more accurately assess recurrence risk and guide patient care.